-
Dimethyloxalylglycine (DMOG) Protocol Guide
2026-09-08
Dimethyloxalylglycine (DMOG), SKU A4506, provides a controlled chemical approach for hypoxia-inducible factor stabilization in cell-based oxygen-sensing, hypoxia signaling, and inflammation studies. This guide covers preparation, controls, and interpretation boundaries; the compound is for scientific research only and should not be used as a diagnostic, therapeutic, or universal in vivo dosing reagent.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody
2026-09-08
A scenario-driven guide to selecting, handling, and interpreting FITC-based mouse IgG detection in immunofluorescence and flow cytometry. It explains how SKU K1201 can support reproducible phenotyping alongside cell viability, proliferation, and cytotoxicity assays.
-
Batimastat (BB-94): Reliable MMP Assays
2026-09-07
Learn how Batimastat (BB-94), SKU A2577, can help researchers distinguish MMP-dependent extracellular effects from nonspecific cytotoxicity in viability, invasion, tumor, and neuromuscular assays. The article connects quantitative potency, solvent handling, controls, and interpretation to practical laboratory decisions.
-
Protease Inhibitor Cocktail: Workflow Guide
2026-09-05
Protect labile proteins, phosphosignals, and protein complexes during cell and tissue disruption with an EDTA-free, broad-spectrum formulation. This guide translates a recent PCNSL single-cell study into practical extraction, immunoprecipitation, kinase-assay, and troubleshooting workflows.
-
Tanshinone IIA Pathways in Psoriasis: Study Insights
2026-09-05
This study combines network pharmacology, molecular docking, keratinocyte assays, and an imiquimod-induced mouse model to explain how tanshinone IIA from Xiao-Yin decoction may suppress psoriasis-associated inflammation. Its central contribution is linking IL-17/IL-23 signaling with the PTGS2/NF-κB/AP-1 axis and showing stronger pathway inhibition when tanshinone IIA is combined with methotrexate.
-
Diuron as a Translational Toxicology Probe
2026-09-04
Diuron is more than a photosynthesis inhibitor: it is a useful probe for connecting exposure chemistry, plant biology research, and emerging renal toxicology evidence. This article presents an evidence-centered framework for choosing assays and interpreting JAK2/STAT1-related findings without conflating biological systems.
-
PGF2α/PTGFR in Endometrial Breakdown
2026-09-04
A 2024 mouse menstrual-like model study identifies PGF2α/PTGFR as a major regulator of endometrial breakdown and vascular permeability after progesterone withdrawal. Its combination of pharmacological inhibition, vascular readouts, and HIF-1α promoter analysis links prostaglandin signaling to a defined transcriptional mechanism with relevance to menstrual biology.
-
Baicalin methyl ester: From Isolation to Barrier Proof
2026-09-03
Baicalin methyl ester connects flavonoid provenance with a structured strategy for proving intestinal barrier protection. This article explains how to interpret pathway, cytokine, tight-junction, and mucosal endpoints without confusing molecular activity with clinical efficacy.
-
2X HyperFusion High-Fidelity Master Mix for CRISPR PCR
2026-09-03
Use the 2X HyperFusion High-Fidelity Master Mix for accurate amplicon generation, blunt-end cloning, and CRISPR target verification when sequence integrity matters. Its premixed format combines proofreading performance, rapid cycling, and practical workflow control for translational cancer research assays.
-
Gingerenone A Reverses Sunitinib Resistance in RCC
2026-09-02
This study identifies gingerenone A as a metabolic inhibitor that targets LDHA-driven glycolysis in renal cell carcinoma and weakens the HIF-1α/VEGFA/VEGFR2 angiogenic axis. Its combination with sunitinib reduced drug resistance in cellular and animal models, providing a mechanistic rationale for metabolic adjuvant strategies rather than a clinically validated treatment.
-
Annexin V-FITC/7-AAD Apoptosis Kit Workflow
2026-09-02
Build a fast, two-parameter cell death analysis workflow with the Annexin V-FITC/7-AAD Apoptosis Kit. The assay separates viable, early apoptotic, late apoptotic, and membrane-compromised cells, making it especially useful for cytotoxicity studies and FLASH-radiotherapy research.
-
Cy5 Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-09-01
Use a Cy5 conjugated secondary antibody to convert rabbit-primary immunoassays into sensitive, spatially resolved readouts across western blotting, ICC, IHC, and flow cytometry. This guide translates the ASB3–MAVS antiviral mechanism into practical assay design, control selection, storage, and troubleshooting decisions.
-
CAR Macrophage Programming for Peritoneal Metastasis
2026-09-01
The reference study develops a macrophage-targeted mRNA lipid nanoparticle system for programming CAR macrophages directly in the peritoneal cavity. By screening 36 CAR designs, the authors identify CD3ζ–TLR4 intracellular domains that preserve inflammatory activity, reshape the tumor microenvironment, and improve responses to PD-1/L1 therapy.
-
Trichostatin A (TSA) in Cancer Research
2026-08-31
Trichostatin A (TSA) provides a reversible way to connect histone acetylation with proliferation, differentiation, and ferroptosis-related phenotypes. This practical guide combines dose-setting, chromatin validation, and HDAC3–NRF2–GPX4 assay design to improve reproducibility in cancer research.
-
PDGF-BB for Pulmonary Hypertension Cell Assays
2026-08-30
Build more informative vascular remodeling assays by using murine recombinant PDGF-BB as a defined mitogenic stimulus alongside hypoxia and metabolic perturbations. This workflow separates receptor-driven smooth muscle cell proliferation from the lactate–ALDOB–DRP1 mechanisms highlighted in recent pulmonary hypertension research.